News & Updates

Ozoralizumab, when used in combination with methotrexate (MTX), appears to yield significant reductions in the signs and symptoms of rheumatoid arthritis (RA) while having an acceptable tolerability, according to data from a double-blind, parallel-group, placebo-controlled phase II/III trial.

In the 5-year follow-up of the ESCAPE trial, exercise-based physical therapy (PT) remained noninferior to arthroscopic partial meniscectomy (APM) for the treatment of symptomatic, degenerative, MRI-confirmed meniscal tears.

Consuming Jarlsberg cheese – a type of Norwegian cheese that contains long-chained vitamin K2 and DHNA* – may help fend off bone weakening, a study from Norway has shown. What’s more, it appears to do so without adversely affecting lipid levels, even extending its benefit to glycated haemoglobin levels.

Olokizumab was superior to placebo and noninferior to adalimumab in achieving ACR20 response* among patients with rheumatoid arthritis (RA) who had an inadequate response to methotrexate maintenance therapy, according to the CREDO2** study.